Frontline immune checkpoint inhibitors in patients ≥ 90 years with advanced urothelial cancer: a single center experience
Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, Maryland, USA
Jun
2024 (Vol.
31, Issue
3, Pages(
11875 - 11879)
PMID: 38912939